IGC Pharma (IGC) FCF Payout Ratio (2011 - 2012)
IGC Pharma (IGC) reported FCF Payout Ratio of 0.33 for Q4 2012, down 93.25% year-over-year from 4.94 in Q1 2012, and down 68.67% quarter-over-quarter from 1.06 in Q3 2012.
IGC Pharma (IGC) FCF Payout Ratio (2011 - 2012) Analysis & Trends
IGC Pharma (IGC) has 2 years of FCF Payout Ratio data on file, last reported at 0.33 in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 0.33 |
| Sep 30, 2012 | 1.06 |
| Jun 30, 2012 | 6.72 |
| Dec 31, 2011 | 4.94 |
| Sep 30, 2011 | 2.05 |
| Jun 30, 2011 | 2.05 |